How to reconstitute retatrutide

Reviewed 11 sourcesPublished by PepVault

How much bacteriostatic water to add to a 5 to 60 mg retatrutide vial, the units each trial dose takes on a U-100 syringe, how to mix it and how to store it.

A hand in a teal sleeve holding a small crimp-sealed powder vial up to the window light, a water vial on a yellow cloth and lemons behind
Last reviewed
Sources
11
Questions
7
Compounds
2

The short answer

Wipe both stoppers, run bacteriostatic water slowly down the inside wall of the vial and swirl, never shake, until it is clear. The water sets the strength: a 10 mg vial with 2 mL is 5 mg/mL, so 2 mg, the phase 3 starting dose, is 40 units on a U-100 syringe. Pick the water so each dose fits one 1 mL syringe (100 units), and keep the vial cold.

Every number checked at its primary source · · 11 sources · How we research

Evidence: The water, strength and units figures are arithmetic on a U-100 syringe; the doses are those of Lilly's phase 3 TRIUMPH trials; handling and storage come from approved products' labels, since no study covers research retatrutide mixed at home.

A hand in a teal sleeve holding a small crimp-sealed powder vial up to the window light, a water vial on a yellow cloth and lemons behind

What do you need to mix a retatrutide vial?

What you need

  • The retatrutide vial, with its milligrams printed on the label.
  • Bacteriostatic water: sterile water with 0.9% or 1.1% benzyl alcohol, a preservative that allows repeated withdrawals from one container6.
  • 1 mL U-100 insulin syringes, where 100 units fill 1 mL10: one for the water, and a new one for every dose7.
  • Alcohol swabs, a pen for the vial's label and a sharps container.

Retatrutide is one peptide that switches on three hormone receptors: GLP-1, GIP and glucagon1. It arrives as a lyophilized (freeze-dried) powder, and in the trials it was a once-weekly injection under the skin11: its half-life, the time for the level in the blood to fall by half, is about six days2. The water never changes how much retatrutide is in the vial, only how concentrated it is. A 20 mg vial holds ten 2 mg doses whether it gets 1 mL or 3 mL. The general method, for any peptide, is in PepVault's guide to reconstituting peptides; this guide is the retatrutide numbers.

Retatrutide is investigational. Lilly states that it is legally available only to participants in its clinical trials and cannot be legally sold or marketed for human use35. No regulator has reviewed what is in a vial from outside a trial, so the milligrams on its label are its maker's own figure.

A smiling woman in a blue top leaning on her kitchen counter with her phone and a notebook

PepVault for iPhone

Keep your protocol in PepVault

PepVault keeps the vial as you recorded it: the strength printed on the label, the day you mixed it and a batch note. Each dose shows the draw you typed as your own record; the app works out no units.

Download on the App Store

7 days free on the yearly plan for new subscribers.

How much bacteriostatic water for each retatrutide vial size?

There is no single correct volume. The water decides the strength, in mg per mL, and the strength decides how many units each dose takes. The table gives the strength of each common vial at the four water amounts PepVault's vial pages chart, from one formula: strength = vial in mg ÷ water in mL.

Vial1 mL2 mL3 mL5 mL
5 mg5 mg/mL2.5 mg/mL1.67 mg/mL1 mg/mL
10 mg10 mg/mL5 mg/mL3.33 mg/mL2 mg/mL
15 mg15 mg/mL7.5 mg/mL5 mg/mL3 mg/mL
20 mg20 mg/mL10 mg/mL6.67 mg/mL4 mg/mL
24 mg24 mg/mL12 mg/mL8 mg/mL4.8 mg/mL
30 mg30 mg/mL15 mg/mL10 mg/mL6 mg/mL
40 mg40 mg/mL20 mg/mL13.33 mg/mL8 mg/mL
60 mg60 mg/mL30 mg/mL20 mg/mL12 mg/mL
Three syringes for the same 2 mg from a 20 mg vial mixed with 1, 2 and 3 mL: 10, 20 and 30 units
Same milligrams, more water: the strength falls and each dose takes more units.

At 10 mg/mL (20 mg with 2 mL, or 30 mg with 3 mL) every 10 units hold 1 mg. At 20 mg/mL (40 mg with 2 mL, or 60 mg with 3 mL) every 10 units hold 2 mg. Odd ones such as 3.33 or 6.67 mg/mL put most doses between the marks. Before planning 3 or 5 mL, check that the vial has room for it.

Try it

Work out your draw

The calculator the app uses. Put in your vial, your water and your dose, and it shows the units to draw on a U-100 syringe.

Try the 3D Reconstitution Lab

Your vial and dose

Example numbers
Draw to 40 units on a U-100 syringe. Lands on a numbered mark. Concentration 5 mg per mL, 5 doses per vial.

Draw to

40unitson a U-100 syringe

Lands on a numbered mark

0.5 mL insulin syringe · 50 units
Concentration
5 mg/mL5,000 mcg/mL
Doses per vial
5

How many units is each retatrutide dose?

In the phase 3 TRIUMPH-1 trial, everyone on retatrutide started at 2 mg once weekly and stepped up every four weeks, through 4, 6 and 9 mg, to a target of 4, 9 or 12 mg34. Those five doses, the ones the trials studied, are the columns below, at the mixes that suit them. Each cell is units = dose in mg × 100 ÷ strength in mg/mL, on a U-100 syringe.

Vial + water (strength)2 mg4 mg6 mg9 mg12 mg
5 mg + 2 mL (2.5 mg/mL)80 unitsmore than one syringemore than the vial holdsmore than the vial holdsmore than the vial holds
10 mg + 2 mL (5 mg/mL)40 units80 unitsmore than one syringemore than one syringemore than the vial holds
10 mg + 1 mL (10 mg/mL)20 units40 units60 units90 unitsmore than the vial holds
20 mg + 2 mL (10 mg/mL)20 units40 units60 units90 unitsmore than one syringe
24 mg + 2 mL (12 mg/mL)about 16.7 units (between marks)about 33.3 units (between marks)50 units75 units100 units (a full 1 mL syringe)
30 mg + 3 mL (10 mg/mL)20 units40 units60 units90 unitsmore than one syringe
40 mg + 2 mL (20 mg/mL)10 units20 units30 units45 units60 units
60 mg + 3 mL (20 mg/mL)10 units20 units30 units45 units60 units
Four 1 mL U-100 syringes from a vial at 10 mg/mL, drawn to 20, 40, 60 and 90 units for the 2, 4, 6 and 9 mg trial steps
At 10 mg/mL each trial step is a numbered mark: look at how the plunger moves while the vial stays the same.

A weak mix that reads well at 2 mg runs out of syringe by 6 mg: at 5 mg/mL, 6 mg is 1.2 mL, more than a 1 mL syringe holds. A mix of 10 mg/mL carries the steps from 2 to 9 mg on numbered marks, and 20 mg/mL is the strength in the table that keeps every step, 12 mg included, inside one syringe on a numbered or clean mark. These are the doses studied in trials, shown so the math has real numbers; they are not a schedule for anyone. Every trial arm is in PepVault's guide to retatrutide dosage in trials.

How do you mix retatrutide, step by step?

  1. Check the vial's milligrams and pick your water from the table above, so you know the strength before the needle goes in.
  2. Wash your hands, flip the plastic caps off the retatrutide vial and the water bottle, and wipe each rubber stopper with an alcohol swab, as Lilly's vial instructions for tirzepatide do7.
  3. Draw the planned millilitres of bacteriostatic water into a syringe. With a 1 mL syringe, 2 or 3 mL takes two or three fills.
  4. Push the needle through the retatrutide stopper, point it at the glass wall and push slowly, so the water runs down the side and not onto the powder.
  5. Swirl the vial in small circles until the powder is gone. Do not shake it: tesamorelin, an approved peptide mixed with bacteriostatic water, is labelled the same way, swirl and do not shake8.
  6. Hold it to the light. It should be clear, with no particles or discoloration6; if it is not, do not use it.
  7. Write the strength and the date on the vial, for example "10 mg/mL, mixed Nov 20". Every dose you draw later is worked out from that strength.
A tilted vial with the needle tip turned to the glass and the water running down the inside wall toward the white powder
Aim at the glass, not the powder: the water runs down the wall and the cake dissolves with a swirl.

PepVault keeps the vial as you recorded it: the strength printed on the label, the day you mixed it and a batch note. Each dose shows the draw you typed as your own record; the app works out no units. Track your vials in PepVault

How do you draw a dose without a units slip?

  1. Take a new U-100 syringe and needle for every dose79. A U-40 syringe holds 40 units per mL, so a U-100 count drawn on it is 2.5 times the volume.
  2. Check the dose against the strength on the vial: 2 mg is 2,000 mcg, and a dose typed in the wrong unit is off by a factor of 1,000.
  3. Wipe the stopper, push the needle in, turn the vial and syringe upside down with the needle tip in the liquid, and pull slowly past your mark7.
  4. Tap the syringe so air bubbles rise, then push the plunger back to the exact line7.

The slip that matters most with vials is a units slip. In reports to the FDA about compounded semaglutide, patients told to draw 5 units on a U-100 syringe drew 50; the agency said unfamiliarity with drawing from a vial and confusion between millilitres, milligrams and units may have contributed10. Retatrutide adds a second trap: in the trial schedules the dose changes every four weeks, so the units change mid-vial while the strength stays the same. At 10 mg/mL, the four trial steps from 2 to 9 mg are 20, 40, 60 and 90 units.

When to get help If an injection site gets redder, more swollen or more painful over the next few days instead of settling, or you get a fever, have a doctor look at it.

How many weeks does each retatrutide vial size last?

Doses per vial depend only on the milligrams, never the water. The CDC allows an opened multi-dose vial 28 days unless its maker states another date9, and 28 days is four weekly doses, so the useful question is how many doses each vial holds at each dose the trials studied:

Dose studied4 weekly doses use10 mg vial20 mg vial30 mg vial60 mg vial
2 mg8 mg5 doses10 doses15 doses30 doses
4 mg16 mg2 doses5 doses7 doses15 doses
6 mg24 mg1 dose3 doses5 doses10 doses
9 mg36 mg1 dose2 doses3 doses6 doses
12 mg48 mgless than 11 dose2 doses5 doses

Any cell above four doses is a vial that outlasts 28 days at that dose. In the trial schedule each step is held for four weeks, so a vial mixed for one step is often still in use when the next step changes its units, the second reason to write the strength on it.

How should you store mixed retatrutide, and for how long?

No published stability data exists for research retatrutide in bacteriostatic water, and there is no retatrutide label to give a storage rule. The water's own label says not to store a reconstituted drug unless that drug's maker says so6. What remains are rules written for other products:

  • The CDC's 28 days: an opened multi-dose vial is dated and discarded within 28 days unless its maker states another date9. It is a limit set for infection control, not a measure of retatrutide's stability.
  • Tirzepatide's label, the closest analogue: Lilly's once-weekly tirzepatide is stored unopened at 2–8 °C, away from heat and light, never used if frozen; its opened multi-dose vial is thrown away 30 days after first use or after 4 weekly doses7. That is a finished product's rule, not retatrutide's.
  • The water bottle: tesamorelin's instructions discard opened bacteriostatic water 28 days after first use8.

Commonly reported: users keep mixed retatrutide in the fridge, away from light, and pick a vial size they finish in about four weeks. That is a habit people report, not a measured shelf life.

If the liquid turns cloudy, grows particles or changes colour, do not use it6. What a step up feels like, and what helps on the queasy days, is in PepVault's guide to retatrutide side effects.

Track it in the app

Sources

  1. Coskun T et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 2022. PubMed 35985340
  2. Urva S et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial. Lancet. 2022. PubMed 36354040
  3. Eli Lilly and Company. Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial. Press release, May 21, 2026. prnewswire.com
  4. Giblin K et al. Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials. Diabetes Obes Metab. 2026. PubMed 41090431
  5. Eli Lilly and Company. Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes. Press release, Sept 29, 2026. prnewswire.com
  6. Hospira. Bacteriostatic Water for Injection, USP: prescribing information. DailyMed. dailymed.nlm.nih.gov
  7. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection: prescribing information and Instructions for Use. Revised 08/2026. DailyMed. dailymed.nlm.nih.gov
  8. Theratechnologies. EGRIFTA WR (tesamorelin) for injection: prescribing information and Instructions for Use. DailyMed. dailymed.nlm.nih.gov
  9. Centers for Disease Control and Prevention. Preventing unsafe injection practices. Injection Safety. cdc.gov
  10. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. 2024. fda.gov
  11. Jastreboff AM et al.; TRIUMPH-1 Investigators. Retatrutide, a triple hormone receptor agonist, for treatment of obesity. N Engl J Med. 2026. PubMed 42814954

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

PepVault for iPhone

Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo